XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.25.1

OTHER INVESTMENTS | 3 Months Ended
--- | ---
Mar. 31, 2025
Investments, Debt and Equity Securities [Abstract] |
OTHER INVESTMENTS | NOTE 4 - OTHER INVESTMENTS SCHEDULE OF OTHER INVESTMENTS
|  | As of March 31, 2025 |  |  | As of December 31, 2024 |
|  | (Unaudited) |  |  | (Audited) |
Investments in equity securities without readily determinable fair values of affiliates: |  |  |  |  |  |  |  |
(1) Greenpro Trust Limited (a related party) |  | $ | 11,981 |  |  | $ | 11,981 |
(2) Other related parties |  |  | 92 |  |  |  | 92 |
Total |  | $ | 12,073 |  |  | $ | 12,073 |
Investments in equity securities without readily determinable fair values of affiliates (related parties): Equity securities without readily determinable fair values are investments in privately held companies without readily determinable market values. The Company adopted the guidance of ASC 321, Investments - Equity Securities, which allows an entity to measure investments in equity securities without a readily determinable fair value using a measurement alternative that measures these securities at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for identical or similar investment of same issuer (the “Measurement Alternative”). The fair value of equity securities without readily determinable fair values that have been remeasured due to impairment are classified within Level 3. Management assesses each of these investments on an individual basis. Additionally, on a quarterly basis, management is required to make a qualitative assessment of whether the investment is impaired. For the three months ended March 31, 2025, the Company recognized a reversal of impairment of investment of $150, whereas for the three months ended March 31, 2024, no impairment or reversal of impairment of investment was recognized. During the year ended December 31, 2024, the Company recognized an impairment of $87,425 for eight of its total investments in equity securities without readily determinable fair values. In addition, the Company recorded its equity securities without readily determinable fair values at cost. For these cost method investments, we recorded them as other investments in our condensed consolidated balance sheets. We reviewed all our cost method investments quarterly to determine if impairment indicators were present; however, we were not required to determine the fair value of these investments unless impairment indicators exist. When impairment indicators exist, we generally adopt the valuation methods allowed under ASC 820 (Fair Value Measurement) to evaluate the fair values of our cost method investments, which approximated or exceeded their carrying values as of March 31, 2025. Our cost method investments had a carrying value of $12,073 as of March 31, 2025.
| (a) | Jocom Holdings Corp.:
On June 2, 2021, our wholly owned subsidiary, Greenpro Venture Capital Limited (“GVCL”), entered into a subscription agreement with Jocom Holdings Corp., a Nevada corporation, which operates a Malaysia-based m-commerce platform specializing in online grocery shopping via smartphones (“Jocom”). Pursuant to the agreement, GVCL acquired 1,500,000 shares of common stock of Jocom at a price of $150 or $0.0001 per share. Upon acquisition, the Company recorded the investment in Jocom at a historical cost of $150 under other investments. For the year ended December 31, 2024, the Company made a full impairment of $150 for the investment in Jocom due to its continuous losses and stockholders’ deficit. As a result, our investment in Jocom was fully impaired with a nil value as of December 31, 2024. On January 24, 2025, GVCL sold all 1,500,000 shares of Jocom’s common stock to an unrelated party, Chu, Hon Pong at a price of $39,950. As a result, GVCL recognized a gain on disposal of other investment of $39,800 and a reversal of impairment of investment of $150 for the three months ended March 31, 2025. The Company had cost method investments without readily determinable fair values with a carrying value of $12,073 as of March 31, 2025, and December 31, 2024, respectively. On March 31, 2025 and December, 31 2024, the carrying values of equity securities without readily determinable fair values are as follows: SCHEDULE OF CARRYING VALUES OF EQUITY SECURITIES WITHOUT READILY DETERMINABLE FAIR VALUES
|  | As of March 31, 2025 |  |  | As of December 31, 2024 |
|  | (Unaudited) |  |  | (Audited) |
Original cost |  |  |  |  |  |  |  |
Balance, beginning of period / year |  | $ | 8,331,139 |  |  | $ | 8,331,964 |
Additions during the year |  |  | - |  |  |  | 92 |
Disposals during the year |  |  | - |  |  |  | (700 | )
Disposal of impaired investment during the period / year |  |  | (150 | ) |  |  | (217 | )
Balance, end of period / year |  |  | 8,330,989 |  |  |  | 8,331,139 |
Accumulated impairment |  |  |  |  |  |  |  |
Balance, beginning of period / year |  |  | (8,319,066 | ) |  |  | (8,231,858 | )
Impairment during the year |  |  | - |  |  |  | (87,425 | )
Disposal of impaired investment during the period / year |  |  | 150 |  |  |  | 217 |
Balance, end of period / year |  |  | (8,318,916 | ) |  |  | (8,319,066 | )
Net carrying values of equity securities without readily determinable fair values |  | $ | 12,073 |  |  | $ | 12,073 |
Accumulated impairment of other investments As of March 31, 2025 and December 31, 2024, the accumulated impairment loss of other investments was $8,318,916 and $8,319,066, respectively.

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for investments in certain debt and equity securities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 940 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/940-320/tableOfContent Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-K (SK) -Number 229 -Section 1403 -Paragraph b -Publisher SEC Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/320/tableOfContent Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-10 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6B Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 320 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/942-320/tableOfContent + Details
Name: | us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration